Exploratory study identifying the benefits of pMDI versus Diskus for delivering fluticasone/salmeterol combination therapy in patients with chronic obstructive pulmonary disease (COPD) First published 09/10/2014 Last updated 21/02/2024 EU PAS number:EUPAS7072 Study Ongoing